Tedisamil
Alternative Names: KC-8857Latest Information Update: 15 Jun 2015
At a glance
- Originator Solvay
- Class Class III antiarrhythmics; Cyclopropanes; Heterocyclic bicyclo compounds; Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atrial fibrillation; Atrial flutter
- Discontinued Angina pectoris; Ischaemic heart disorders
Most Recent Events
- 15 Jun 2015 No recent reports on development identified - Registered for Atrial fibrillation in Spain and United Kingdom (IV)
- 15 Jun 2015 No recent reports on development identified - Registered for Atrial flutter in Spain and United Kingdom (IV)
- 26 Mar 2009 Tedisamil is available for licensing in Europe (http://www.solvay.com)